| Literature DB >> 30014250 |
L Bell1,2, A Wittkowski2, D J Hare3.
Abstract
Movement disorders are reported in idiopathic autism but the extent to which comparable movement disorders are found in syndromic/co-morbid autism is unknown. A systematic search of Medline, Embase, PsychINFO and CINAHL on the prevalence of specific movement disorder in syndromic autism associated with specific genetic syndromes identified 16 papers, all relating to Angelman syndrome or Rett syndrome. Prevalence rates of 72.7-100% and 25.0-27.3% were reported for ataxia and tremor, respectively, in Angelman syndrome. In Rett syndrome, prevalence rates of 43.6-50% were reported for ataxia and 27.3-48.3% for tremor with additional reports of dystonia, rigidity and pyramidal signs. However, reliable assessment measures were rarely used and recruitment was often not described in sufficient detail.Entities:
Keywords: Angelman; Ataxia; Autism; Dystonia; Extra-pyramidal; Movement disorder; Retts; Rigidity; Tremor
Mesh:
Year: 2019 PMID: 30014250 PMCID: PMC6331489 DOI: 10.1007/s10803-018-3658-y
Source DB: PubMed Journal: J Autism Dev Disord ISSN: 0162-3257
Summary of search terms
| Angelman syndrome | ‘angelman’ OR ‘happy puppet’ OR Angelman Syndrome (MESH term) OR happy puppet syndrome (MESH term) |
| CHARGE syndrome | ‘charge syndrome’ OR ‘hall-hittner’ OR ‘hall hittner’ OR CHARGE syndrome (MESH term) |
| Cohen syndrome | ‘cohen’ OR ‘pepper syndrome’ OR Cohen Syndrome (MESH term) |
| Cornelia de Lange syndrome | ‘cornelia de lange’ OR ‘cornelia-de-lange’ OR ‘brachmann de lange’ OR ‘brachmann-de-lange’ OR ‘cdls’ OR ‘bdls’ OR ‘de lange’ OR ‘de-lange’ OR ‘amsterdam syndrome’ OR Cornelia de Lange Syndrome (MESH term) OR De Lange Syndrome (MESH term) |
| Fragile X syndrome | ‘fragile x’ OR ‘fragile-x’ OR ‘fragile site’ OR ‘fxs’ OR ‘fra(X)’ OR ‘fraX’ OR ‘FMRP’ OR ‘marker x’ OR ‘martin-bell’ OR ‘martin bell’ OR ‘x-linked mental retardation’ or Fragile X Syndrome (MESH term) OR Mental Retardation, X-Linked (MESH term) |
| Rett syndrome | ‘rett’ OR ‘rtt’ OR Rett Syndrome (MESH term) |
| Tuberous sclerosis complex | ‘tuberous sclerosis’ OR ‘tuberose sclerosis’ OR ‘TSC’ OR ‘phakomatosis ts’ OR ‘bourneville pringle’ OR Tuberous Sclerosis (MESH term) |
| Movement disorder | ‘movement’ OR ‘motor’ OR ‘movement disorder*’ OR ‘ataxi*’ OR ‘apraxi*’ OR ‘gait’ OR ‘tremor’ OR ‘parkinson*’ OR ‘dyskinesia’ OR ‘akinesia’ OR ‘cataton*’ OR Movement (MESH term) OR Motor Skills Disorder (MESH term) OR Movement Disorders (MESH term) OR Ataxia (MESH term) OR Apraxias (MESH term) OR Gait (MESH term) OR Gait Disorders (MESH term) OR Tremor (MESH term) OR Parkinsonian Disorders (MESH term) OR Dyskinesias (MESH term) OR Catatonia (MESH term) |
Fig. 1PRISMA diagram for selection of papers
Sample characteristics, methodology, and quality assessment for studies reporting the prevalence of movement disorders in Angelman syndrome and Rett syndrome
| Authors | Syndrome | N | % Male | Age range | Genetic mechanism | Recruitment information | Assessment method | Movement disorders identified | % Prev. ( | Risk of bias |
|---|---|---|---|---|---|---|---|---|---|---|
| Bai et al. ( | Angelman | 30 | 50.0 | 2.7–9.6 years at last observation | Deletion | Sample of children with Angelman syndrome in China—recruitment method not specified | Purpose-made questionnaire based on clinical criteria | Ataxic movement | 100% (24) of those able to walk | Moderate |
| Beckung et al. ( | Angelman | 11 | Unclear for subgroup with DNA confirmation | Unclear for subgroup with DNA confirmation | Not reported | Individuals referred to a Children’s Hospital in Sweden for investigation of Angelman syndrome | Extensive clinical investigation—movement problems classified based on performance | Gait ataxia | 72.7% (8) | Moderate |
| Buoni et al. ( | Angelman | 11 | 54.5 | 1 year 6 months to 15 years at last observation | 10 deletion | Genetic screening of 144 patients at Paediatric Institute | Medical records, history and clinical examination | Ataxia | 100% (11) | Moderate |
| Clayton-Smith ( | Angelman | 28 | 42.9 | 16–40 years | 19 deletion | Participated in a previous study or seen personally by the author | Medical notes, parent/carer-reported history and clinical examination | Ataxic gait | 100% (28) | Moderate |
| Guerrini et al. ( | Angelman | 11 | 45.5 | 3–28 years | 8 deletion | Unclear | Rated scale score based on observation | Jerky, tremulous, dystonic movement | 100% (11) | Moderate |
| Moncla et al. ( | Angelman | 14 | 57.1 | 9 months–33 years at diagnosis (Not reported) | All UBE3A mutation | Referred to the authors in Department of Genetic Medicine | Clinical history, anthropometric data and physical and neurological findings | Ataxia | 100% (14) total | Moderate |
| Saitoh et al. ( | Angelman | 40 | 47.5 | Unclear | 37 deletion | Large sample of individuals with Angelman syndrome in Japan – recruitment method not specified | Questionnaires completed by physicians | Ataxic movement | 97.1% (34) of those for whom ataxic movement data reported | High |
| Sandanam et al. ( | Angelman | 11 | 81.8 | 24–36 years at last review | All deletion | Genetic screening of residents of two residential institutions | Review of records, history and clinical examination completed by two clinicians | Ataxic gait | 100% (9) of those able to walk | Moderate |
| Smith et al. ( | Angelman | 27 | 33.3 | 3–34 years at last review (M 11.2 years) | Deletion | Referrals for genetic testing from physicians across Australia and New Zealand as part of a research grant | Data sheet based on clinical criteria plus medical records, parent interviews, photos and videos where available, and either correspondence with referrer or clinical examination by authors | Ataxia—wide-based gait, unsteadiness with jerky movements or thumping heavy gait | 100% (27) | Moderate |
| Smith et al. ( | Angelman | 4 | 50.0 | 7–11 years (M 8 years) | Uniparental disomy | As above | Data sheet based on clinical criteria, plus medical records, parent interviews and correspondence with referrer | Ataxia | 100% (4) total | High |
| Tan et al. ( | Angelman | 92 | 54.3 | 5–60 months | 68 deletion | Part of a multi-centre study with enrolment through support groups and referral from professionals | Structured medical history and physical examination by a clinical geneticist | Ataxic gait | 87.8% (36) of those able to walk | Moderate |
| Zori et al. ( | Angelman | 16 | Unclear | Unclear—children | Deletion | American families with a child with Angelman syndrome —recruitment method not specified for these families | Family questionnaire assessing clinical, cytogenetic and developmental variables, plus physical examination and lab data | Ataxic gait | 81.3% (13) | Moderate |
| Bartholdi et al. ( | Rett | 4 | 0 | 4–19 years at last observation | Exon 1 mutation/genomic rearrangement in MECP2 | Recruited from a larger cohort of individuals with Rett syndrome in Switzerland. No further details | Medical records and clinical examination | Gait ataxia | 25,% (1), 50% of those walking | Moderate |
| Einspieler et al. ( | Rett | 12 | 0 | 0–6 months | 6 truncating mutations, 3 missence mutations, 2 deletions, 1 substitution at 401 | Videotapes donated by British families to the project | Videotapes analysed by two observers | Tremor | 27.3% (3) | Moderate |
| Smeets et al. ( | Rett | 10 | 0 | 3–54 years at diagnosis | Hotspot deletion in C-terminal segment of MECP2 | Seen by first author clinically—Clinical Genetics Department in a University Hospital in Belgium | Observed and assessed by first author and parents/carers | ‘Awkward’ walking pattern | 20.0% (2) | Moderate |
| Temudo et al. ( | Rett | 60 | Not reported. Not all female | 5–13.5 years | 26 missence mutations, 34 truncating mutations | Referred to the project by any Paediatric Neurologist across Portugal | Motor-Behavioral Assessment Scale for Rett syndrome | Ataxia | 35.0% (21) | Moderate |
| Ataxic/rigid gait | 43.6% (unclear) | |||||||||
| Dystonia | 63.3% (38) | |||||||||
| Rigidity | 48.3% (29) | |||||||||
| Pyramidal signs | 28.3% (17) | |||||||||
| Tremor | 48.3% (29) |
Summary of risk of bias ratings by paper
| Author | Sample represents national population | Sample represents target population | Random selection | Non-response bias | Direct measure | Case definition given | Reliable and valid measure | Same data collected from all | Appropriate prevalence period | Numerator/denominator appropriate | Summary rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Angelman syndrome papers | |||||||||||
| Bai et al. ( | High | High | High | High | High | High | High | Low | Low | Low | Moderate |
| Beckung et al. ( | High | High | High | High | Low | Low | High | Low | Low | Low | Moderate |
| Buoni et al. ( | High | High | High | High | Low | High | High | Low | Low | Low | Moderate |
| Clayton-Smith (2001) | High | High | High | High | High | High | High | Low | Low | Low | Moderate |
| Guerrini et al. ( | High | High | High | High | Low | Low | High | Low | Low | Low | Moderate |
| Moncla et al. ( | High | High | High | High | Low | High | High | Low | Low | Low | Moderate |
| Saitoh et al. ( | High | High | High | High | High | High | High | Low | High | High | High |
| Sandanam et al. ( | High | High | High | Low | Low | High | High | Low | Low | Low | Moderate |
| Smith et al. ( | Low | High | High | High | High | Low | High | High | High | Low | Moderate |
| Smith et al. ( | Low | High | High | High | High | High | High | Low | High | High | High |
| Tan et al. ( | High | Low | Low | High | Low | High | High | Low | Low | Low | Moderate |
| Zori et al. ( | Low | High | High | High | Low | High | High | Low | Low | Low | Moderate |